Download PDF
Dtsch Med Wochenschr 2002; 127(3): 89-93
DOI: 10.1055/s-2002-19589
Aktuelle Diagnostik & Therapie
© Georg Thieme Verlag Stuttgart · New York

Therapie des akuten Nierenversagens[1]

Treatment of acute renal failureS. R. Lederer, T. Sitter, H. Schiffl
  • Nephrologisches Zentrum - Innenstadt (Direktor: Prof. Dr. med. D. Schlöndorff), Klinikum der Universität München
Further Information

Publication History

Manuskript-Eingang: 29. Oktober 2001

Annahme nach Revision: 21. November 2001

Publication Date:
17 January 2002 (online)

Also available at
   Permissions and Reprints
Preview

Nach wie vor ist die einzige kausale Behandlung des akuten Nierenversagens (ANV) die Therapie der Grundkrankheit, sei sie extrarenal - oder renal - bedingt. Präventive Maßnahmen und Therapiekonzepte in der Initialphase des ANV sind daher von herausragender Bedeutung. Eine spezifische Therapie ist bei prärenaler Azotämie oder obstruktiver Nephropathie möglich, nicht jedoch bei manifestem ANV aufgrund ischämisch- toxischer Tubulusnekrose. Ziel geeigneter supportiver Maßnahmen und des adäquaten Einsatzes der Nierenersatztherapie ist es, lebensbedrohliche Komplikationen des vollständigen Verlustes der exkretorischen Nierenfunktion zu vermeiden.

1 Der Beitrag »Diagnostik des akuten Nierenversagens« ist im vorhergehenden Heft (Nr. 1/2) erschienen.

Literatur

  • 1 Abramson S, Singh A K. Continous renal replacement therapy compared with intermittend hemodialysis in intensive care: which is better?.  Curr Opin Nephrol Hypertens. 1999;  8 537-541
    Search in Google Scholar
  • 2 Allgren R L, Marbury C, Rahman S N. et al . Anaritide in acute tubular necrosis.  N Engl J Med. 1997;  336 828-834
    Search in Google Scholar
  • 3 Barrett B J, Carlisle E J. Metaanalysis of the relative nephrotoxicity of high and low-osmolality iodinated contrast media.  Radiology. 1993;  188 171-178
    Search in Google Scholar
  • 4 Berns A S. Nephrotoxicity of contrast media.  Kidney Int. 1989;  36 730-740
    Search in Google Scholar
  • 5 Burke T J, Arnold P E, Gordon J A, Bulger R E, Dobyan D C, Schrier R W. Protective effect of intrarenal calcium membrane blockers before or after renal ischemia.  J Clin Invest. 1984;  74 1830-1841
    Search in Google Scholar
  • 6 Chertow G M, Lazarus J M, Paganini E P, Allgren R L, Lafayette R A, Sayegh M H. The Auricullin Anaritide Acute Renal Failure Study Group . Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis.  J Am Soc Nephrol. 1998;  9 692-698
    Search in Google Scholar
  • 7 Erley C M, Duda S H, Rehfuss D. et al . Prevention of radiocontrast-media induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline.  Nephrol Dial Transplant. 1999;  14 1146-1149
    Search in Google Scholar
  • 8 Franklin S C, Moulton M, Sicard G A, Hammermann M R, Miller S B. Insulin-like growth factor I preserves renal function postoperatively.  Am J Physiol. 1997;  272 F257-259
    Search in Google Scholar
  • 9 Hatala R, Dinh T, Cook D J. Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis.  Ann Intern med. 1996;  124 717-725
    Search in Google Scholar
  • 10 Hirschberg R, Kopple J, Lipsett P. et al . Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure.  Kidney Int. 1999;  55 2423-2432
    Search in Google Scholar
  • 11 Ichai C, Passeron C, Carles M, Bouregba M, Grimaud D. Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable, critically ill patients: a single-blind, prospective, controlled study.  Crit Care Med. 2000;  28 1329-1335
    Search in Google Scholar
  • 12 Jörres A, Gahl G M, Dobis C. et al . Haemodialysis-membrane biocompatibility and mortality of patients wih dialysis-dependent acute renal failure: a prospective randomised multicentre trial.  Lancet. 1999;  354 1337-1341
    Search in Google Scholar
  • 13 Kellum J A. Use of diuretics in the acute care setting.  Kidney Int. 1998;  53 S67-S70 (Suppl 66))
    Search in Google Scholar
  • 14 Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery.  J Am Soc Nephrol. 2000;  11 97-104
    Search in Google Scholar
  • 15 Lehnert T, Keller E, Gondolf K, Schäffner T, Pavenstädt H, Schollmeyer P. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.  Nephrol Dial Transplant. 1998;  13 358-362
    Search in Google Scholar
  • 16 Levy E M, Viscoli C M, Horwitz R I. The effect of acute renal failure on mortality: A cohort analysis.  JAMA. 1996;  275 1489-1494
    Search in Google Scholar
  • 17 Lewis J, Salem M M, Chertow G M, Weisberg L S, Mc Grew  F, Marbury T C, Allgren R L. Anaritide acute renal failure study group . Atrial natriuretic factor in oliguric acute renal failure.  Am J Kidney Dis. 2000;  36 767-774
    Search in Google Scholar
  • 18 Marik P E, Iglesias J. NORASEPT II Study Investigators . Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria.  Am J Med. 1999;  107 387-390
    Search in Google Scholar
  • 19 Neumayer H H, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomized clinical trial.  Nephrol Dial Transplant. 1989;  4 1030-1036
    Search in Google Scholar
  • 20 Noiri E, Peresleni T, Miller F, Goligorsky M S. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia.  J Clin Invest. 1996;  97 2377-2383
    Search in Google Scholar
  • 21 Nolan C R, Anderson R J. Hospital aquired acute renal failure.  J Am Soc Nephrol. 1998;  9 710-718
    Search in Google Scholar
  • 22 Rabb H, O¿Meara Y, Maderna P, Coleman P, Brady H R. Leucocytes, cell adhesion molecules and ischemic acute renal failure.  Kidney Int. 1997;  51 1463-1468
    Search in Google Scholar
  • 23 Rahman S N, Kim G E, Mathew A S. et al . Effects of atrial natriuretic peptide in clinical acute renal failure.  Kidney Int. 1994;  45 1731-1738
    Search in Google Scholar
  • 24 Rodicio J L, Ruilope L M. Assessing renal effects and renal protection.  J Hypertens Suppl. 1995;  13 S19-S25
    Search in Google Scholar
  • 25 Ronco C, Bellomo R, Homl P. et al . Effects of different doses in continous veno-venous haemofilration on outcomes of acute renal failure: a prospective randomised trial.  Lancet. 2000;  356 26-30
    Search in Google Scholar
  • 26 Rudnick M R, Berns J S, Cohen R M, Goldfarb S. Contrast media-associated nephrotoxicity.  Curr Opin Nephrol Hypertens. 1996;  5 127-123
    Search in Google Scholar
  • 27 Ruschitzka F, Shaw S, Gygi D, Noll G, Barton M, Lüscher T F. Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.  J Am Soc Nephrol. 1999;  10 953-962
    Search in Google Scholar
  • 28 Schiffl H, Lang S M, König A, Strasser T, Haider M C, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study.  Lancet. 1994;  344 570-572
    Search in Google Scholar
  • 29 Shilliday I R, Quinn K J, Allison M E. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-contolled, randomized study.  Nephrol Dial Transplant. 1997;  12 2592-2596
    Search in Google Scholar
  • 30 Singer I, Epstein M. Potential of dopamine A-1 agonists in the management of acute renal failure.  Am J Kidney Dis. 1998;  31 743-755
    Search in Google Scholar
  • 31 Solomon R, Werner C, Mann D, D¿Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal fuction induced by radiocontrast agents.  N Engl J Med. 1994;  331 1416-1420
    Search in Google Scholar
  • 32 Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.  N Engl J Med. 2000;  343 180-184
    Search in Google Scholar
  • 33 Zager R A. Rhabdomyolysis and myohemoglobinuric acute renal failure.  Kidney Int. 1996;  45 314-326
    Search in Google Scholar

1 Der Beitrag »Diagnostik des akuten Nierenversagens« ist im vorhergehenden Heft (Nr. 1/2) erschienen.

Korrespondenz

Dr. Stephan R. Lederer

Klinikum der Universität München, Medizinische Klinik - Innenstadt

Ziemssenstraße 1

80336 München

Phone: 089/51602111

Fax: 089/51604924

Email: slederer@medinn.med.uni-muenchen.de